Phase 3 study for people with Stroke

Recruiting Phase 3

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 3
Sponsor Insel Gruppe AG, University Hospital Bern
Registry number NCT04873583
Started 16 November 2021 Today 16 October 2026 Estimated completion 1 July 2026

Past estimated completion. The registry still lists this trial as open, and the date it gave for finishing has been and gone. Confirm with the official record before you act on it.

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Sydney Childrens Hospital Randwick Randwick NSW Recruiting
Sydney Childrens Hospital Network Westmead NSW Recruiting
Melbourne Childrens Hospital Melbourne VIC Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 6 Months to 17 Years
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 70

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

1. Informed consent of the legal representative of the trial participant documented by signature

2. Age \> 6 months \& \< 18 years at time of stroke

3. Randomisation possible within 48 hours of diagnosis and maximum 96 hours after stroke onset

4. Unilateral arteriopathy according to the following criteria:

* Newly acquired neurologic deficits

* Specific neuroimaging (MRA) features of either

* unilateral stenosis, or

* unilateral vessel irregularities within the Central Nervous System (CNS)

5. Unless otherwise defined in the national addendum: Female participants age ≥ 13: Negative pregnancy test (blood or urine)

Exclusion Criteria:

1. Previous stroke

2. Known syndromal disorders, as e.g. Trisomy 21, Neurofibromatosis type 1

3. Known genetic vasculopathies as e.g. posterior fossa anomalies, hemangioma, arterial anomalies, cardiac anomalies and eye anomalies syndrome (PHACES), actin alpha 2 (ACTA II)

4. Moyamoya or sickle cell disease

5. Small vessel cerebral vasculitis (primary CNS vasculitis)

6. Bilateral arteriopathy

7. Arterial dissection(s)

8. Evidence of underlying systemic disorders, as e.g. lupus, rheumatoid problems

9. Secondary CNS angiitis due to infections (meningitis, endocarditis, borreliosis), or generalised angiitis due to rheumatic or other autoimmune problems

10. Progressive large to medium childhood primary angiitis of the CNS (cPACNS ) with 2 of the following 3 criteria:

1. pre-existing progressive neurocognitive dysfunction

2. bilateral MRI lesions/vessel involvement

3. small vessel arterial stenosis

11. On steroid treatment at disease onset

12. Contraindication to steroid treatment as e.g. a congenital or acquired immunodeficiency

13. Inability to follow the procedures of the study, e.g. due to language problems

14. Participation in another interventional study within the 30 days preceding the indication stroke and during the present study

Dates on the record

Started 16 November 2021
Estimated completion 1 July 2026
Registry last updated 18 November 2025
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 18 November 2025.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.